CXCR2 and cancer: CAFs in turn, secrete C-X-C motif chemokine 5 (CXCL5), which binds to c-x-c motif chemokine receptor 2 (CXCR2) on cancer cells, resulting in PI3K pathway activation and downregulation of PD-L1 [58].